BMB-105

N/A

Report date: 2025/12/31 17:33:33

Base Information

Drug NameBMB-105
Drug Alias NameBMB-105BMB105
ClassificationOther
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBright Minds Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBright Minds Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPrader-Willi Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A